All
Santen, jCyte Sign Licensing Contract for Investigational Retinitis Pigmentosa Therapy
May 14th 2020Santen Pharmaceutical has concluded a licensing agreement with jCyte for the development, registration, and commercialization rights to jCell, an investigational retinitis pigmentosa therapy, in Japan, Asia, and Europe.
HCATS, apceth Biopharma Form Strategic Manufacturing Agreements with bluebird bio
May 13th 2020Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma entered into long-term development and manufacturing services agreements for the clinical and commercial supply of multiple bluebird bio therapies.
IMA Holds Virtual Event to Demonstrate Technology Advancements in Packaging and Processing
May 13th 2020In light of the current social distances measures, in place as a result of COVID-19, IMA Digital, part of IMA Group, has been providing virtual experiences for those interested in packaging and processing.
Novavax to Receive up to $384 Million in Funding from CEPI for COVID-19 Vaccine Candidate
May 12th 2020The Coalition for Epidemic Preparedness Innovations will invest up to $384 million of additional funding, in addition to the $4 million it invested in March, to advance the clinical development of NVX-CoV2373, Novavax’s COVID-19 vaccine candidate.